Skip to main content
CKD Bio Corp. logo

CKD Bio Corp. — Investor Relations & Filings

Ticker · 063160 ISIN · KR7063160006 LEI · 988400RFJ8DLB1NTOE10 KO Manufacturing
Filings indexed 146 across all filing types
Latest filing 2024-10-25 Earnings Release
Country KR South Korea
Listing KO 063160

About CKD Bio Corp.

https://www.ckdbio.com/en/home

CKD Bio Corp. is a pharmaceutical company specializing in fermentation and chemical synthesis technologies. The company develops and manufactures a range of products, including Active Pharmaceutical Ingredients (APIs), intermediates, and probiotics. Its API portfolio features fermentation-based products such as antibiotics, ß-lactamase inhibitors, and immunosuppressants. Leveraging extensive experience in fermentation, CKD Bio also produces next-generation probiotics using patented technology. Additionally, the company provides Contract Manufacturing (CMO) and Contract Research (CRO) services for APIs and intermediates, utilizing its cGMP-certified production facilities.

Recent filings

Filing Released Lang Actions
영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Preliminary Earnings Release' (영업(잠정)실적) for Chong Kun Dang Bio for the third quarter of 2024. It provides key financial highlights such as revenue, operating profit, and net income, comparing them to previous periods. It is a concise summary of financial performance, which fits the definition of an Earnings Release (ER). Q3 2024
2024-10-25 Korean
반기보고서 (2024.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for the company '종근당바이오' (CKD Bio Corp.) covering the period from January 1, 2024, to June 30, 2024. It contains detailed financial statements, management discussion and analysis, and corporate governance information, which is characteristic of an interim/quarterly report. It is not a mere announcement or certification, as it contains substantive financial data and operational details. H1 2024
2024-08-14 Korean
영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Release' (영업(잠정)실적) for Chong Kun Dang Bio for the second quarter of 2024. It provides key financial highlights such as revenue, operating profit, and net income in a table format, explicitly stating these are provisional figures (잠정치) and have not been audited. This fits the definition of an Earnings Release (ER), which is the initial announcement of periodical financial results. Q2 2024
2024-07-26 Korean
투자판단관련주요경영사항
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from Chong Kun Dang Bio regarding a 'Major Management Matter' (투자판단 관련 주요경영사항), specifically the application for product approval of a new drug (Timeverse Injection) to the Ministry of Food and Drug Safety. It details clinical trial results, efficacy, safety, and future commercialization plans. Since it is a specific regulatory announcement of a material corporate event that does not fit into categories like financial reports, dividends, or board changes, it is classified as a Regulatory Filing (RNS).
2024-05-24 Korean
분기보고서 (2024.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'Chong Kun Dang Bio' (종근당바이오) covering the period from January 1, 2024, to March 31, 2024. It contains detailed financial statements, business descriptions, and management analysis, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2024
2024-05-16 Korean
영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Report' (영업(잠정)실적) for Chong Kun Dang Bio for the first quarter of 2024. It provides key financial highlights such as revenue, operating profit, and net income, which are typical of an initial earnings release. It is not a full report but a summary of preliminary results, fitting the definition of an Earnings Release (ER). Q1 2024
2024-04-26 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.